CIK 0001810182
- Non-accelerated filer
- Smaller reporting company
ALX ONCOLOGY HOLDINGS INC
Sign in to watch- Ticker
- ALXO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 850642577
- Phone
- +1 650-466-7125
- Business address
- 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale PRESIDENT & CSO sold 20,000 shares at $8.43 ($168,652)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 12,000 shares at an average $15.94 ($191,339)
- 4 Planned sale PRESIDENT & CSO sold 20,000 shares at $15.92 ($318,334)
- 4 Planned sale PRESIDENT & CSO sold 50,000 shares at $14.20 ($710,195)
- 4 Planned sale PRESIDENT & CSO sold 20,000 shares at $11.15 ($223,036)
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 4,400 shares at $11.31 ($49,771)
- 4 Grant or award SVP, FINANCE AND CAO acquired 15,000 shares (grant or award)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 25,000 shares (grant or award)
- 4 Grant or award CHIEF MEDICAL OFFICER acquired 30,000 shares (grant or award)
- 4 Grant or award PRESIDENT & CSO acquired 30,000 shares (grant or award)
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 60,000 shares (grant or award)
- 4 Open-market sale SVP, Finance and CAO sold 2,717 shares at $13.60 ($36,957)
- 4 Open-market sale SVP, Finance and CAO sold 1,631 shares at $15.04 ($24,530)
- 4 Open-market sale Chief Medical Officer sold 3,128 shares at $15.04 ($47,045)
- 4 Open-market sale Chief Financial Officer sold 1,893 shares at $15.04 ($28,471)
- 4 Open-market sale President & CSO sold 7,179 shares at $15.04 ($107,972)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Medical Officer acquired 34,000 shares (grant or award)
Page 5 of 11 · 213 filings